Circulars and admission document REGISTER FOR EMAIL ALERTS Circular 29.06.21 PDF Circular – Form of Proxy 29.06.21 PDF Amryt Notice of General Meeting 29.06.21 PDF GM Proxy Form 29.06.21 PDF Articles of Association of Amryt Pharma PLC. July 2020 (red-lined) PDF Amryt Notice of Annual General Meeting 30.06.20 PDF Amryt AGM Proxy Form 30.06.20 PDF Amryt Equity Incentive Plan PDF Amryt Equity Incentive Plan: Sub-plan for US participants PDF Admission Document 27.08.2019 PDF Restructuring Support Agreement PART I PDF Restructuring Support Agreement PART II PDF Aegerion – Plan Funding Agreement PART I PDF Aegerion – Plan Funding Agreement PART II PDF Grant Thornton Consent Letter PDF Stiftung Signed Undertaking PDF DIP Credit Agreement PDF Cooley – Patent Report PDF Joe Wiley – Signed Undertaking PDF Rory Nealon – Signed Undertaking PDF Shore Capital QFBS Report PDF Shore Capital Consent Letter PDF Ray Stafford – Signed Undertaking PDF Aegerion Patent Report PDF Secured Credit Facility PDF Aegerion – Contingent Value Rights Deed Poll PDF Backstop Subscription Agreement PDF Convertible Notes PDF Registration Rights Agreement PDF New Amryt – Articles PDF Aegerion Consent Letter PDF Aegerion Report on QFBS PDF Haug Partners Consent Letter PDF New Warrant Instrument PDF MTS QFBS Report PDF MTS Consent Letter PDF Aegerion – Deloitte Accountant Report PDF Amryt Pharma Plc Consent Letter PDF Davy Signed Consent Letter PDF Aegerion Constitutional Documents PDF Court Meeting Proxy PDF General Meeting Proxy PDF Amryt Notice of Annual General Meeting 10.07.2019 PDF Amryt Notice of Annual General Meeting 05.06.2018 PDF Amryt AGM Proxy Form 05.06.2018 PDF Amryt Proxy Form October 2017 PDF Amryt Circular October 2017 PDF Amryt Notice of Annual General Meeting 25.05.2017 PDF Amryt AGM Proxy Form 25.05.17 PDF Admission Document May 2017 PDF Admission Document April 2016 PDF Fastnet Notice of Annual General Meeting 30.09.2015 PDF Fastnet Circular 28.08.2015 PDF Fastnet GM Proxy Form 28.08.15 PDF Notice of Annual General Meeting 07.07.2016 PDF We transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need. Privacy policy | Terms and Conditions Cookie policy | Fraud warning Accessibility | Sitemap Website Last updated: 04/08/2021 | Copyright © 2021 Amryt Pharma plc We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie Settings Accept All